Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

1
Player Avatar theory6453 (23.31) Submitted: 1/11/2012 8:12:46 AM : Outperform Start Price: $38.00 MRK Score: -3.80

Babo

Featured Broker Partners


Advertisement